Articles & Video
Seven women forging the future of healthcare with AI
Artificial intelligence is beginning to have an important impact on human health. We profile seven women who are using AI to solve some of healthcare’s biggest problems.
Using Wearables in Clinical Trials: Going Beyond the Hype - WHITEPAPER
Wearables in clinical trials may fundamentally change how studies are designed and conducted. This whitepaper looks at successful case studies.
A Backstage View Of Roche’s Recent Collaborations
In an exclusive interview, Barbara Lueckel, global head of research technologies at Roche Pharma Partnering, talks about the rationale behind the 2020 deals with Bicycle Therapeutics and Nimble Therapeutics. She gives insight into how deal makers are shifting gears to make deals happen in the challenging environment of the global coronavirus pandemic.
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel
Future improvements in cancer care are most likely to stem from combinations therapies and data-driven prevention efforts, as well as breakthrough drugs. That’s the message life sciences experts shared this week during a webcast on the topic of “oncology’s next decade” recorded for the BIO-Europe Spring partnering conference.
MedTech Report 2020: EU MDR and IVDR Compliance
Download the MedTech Report 2020 on EU MDR and IVDR Compliance, based on 265 survey responses from industry insiders.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Servier BioInnovation: A global innovation engine to boost early-stage R&D through partnering
In today’s rapidly changing and ever-evolving global biomedical innovation ecosystem, collaboration and partnerships are key to R&D success to ensure the development of a sustainable pipeline of innovative new medicines.
Raising hope and awareness on World Rare Disease Day
Join EBD Group in observing World Rare Disease Day (WRDD) on February 29 and raising awareness of the difficult challenges faced by more than 400 million people around the world who suffer from a rare disease. On average, one out of ten people is affected by a rare disease, and three out of ten children with a rare disease will not live to see their fifth birthday.
Regulatory challenges for Software as Medical Device (SaMD) and AI
We asked six medical device industry experts about the regulatory challenges of Software as Medical Device (SaMD) and Artificial Intelligence.
New approaches to drug discovery and development enabled by platform success
Relatively small Enabling Technology Platform companies are changing the future for patients, drug discovery scientists, therapeutic scientists, developers, new therapy approach scientists, plus payers. Sometimes, it is important to remind oneself that biotech is working for the good of the worldwide healthcare industry and not just our local markets.
The 2020 Outlook for Europe
Discover insights and gain helpful advice in this curated article pack from Informa Pharma Intelligence on biotech, regulations, pharma, and financial investment in Europe and the United Kingdom.
China Bio: Change and opportunity are constant
Rapid, unrelenting changes are altering China’s biotech landscape in 2020. Speakers at China Showcase in San Francisco last month focused on the fundamentals of this maturing market.
Paris Region to lead the field in personalized medicine and biopharma 3.0
Medicen Paris Region is thrilled to host the 2020 edition of BIO-Europe Spring following the great success of the 2015 conference here. The Paris Region is a worldwide hub when it comes to healthcare innovation, and the very first European region when it comes to biopharma specifically. It is indeed home to 1,000+ life sciences startups, more than 1,200 public and private R&D labs and 12,000 life sciences researchers, and Europe’s largest hospital network.
What's shaping the future of biotech?
Could the November presidential election impact drug prices? What does the investment landscape look like for this year? Download the free article pack to discover how financial and biotech experts tackled these questions and many more at Biotech Showcase™ and Digital Medicine & Medtech Showcase.
PharmAI – Industry is Smartening Up to Potential of Artificial Intelligence
Artificial Intelligence (AI) has enormous potential in changing the delivery of health care and improving patient outcomes, with applications in pattern detection, patient monitoring, disease diagnosis and treatment selection. The rationale is that AI can be used to enhance the decision-making process, taking into account far more data than are available to physicians via conventional means.
Tracking the Power of Presenting at Biotech Showcase
For the first time, Informa Pharma Intelligence explores the achievements by Biotech Showcase presenting companies, delving into the deal-making activity that has occurred for companies who have presented at the conference in the last five years.
The Power of Presenting at Biotech Showcase
Informa Pharma Intelligence analysts took a deep dive into what has happened to companies who have presented at Biotech Showcase. Since 2015, over 250 companies that have presented at Biotech Showcase have generated deals worth over $61bn.
Digital Therapeutics – Treating the cost of care
What are Digital Therapeutics and how can they help make healthcare more affordable? We explore.
Giving a Pharma Giant a Tech Startup Makeover
This shows how we’re using data and digital to reimagining medicine. If successful, this could open up the entire area of digital therapeutics.
Digital Health: Advancing innovation through technology and strategic partnerships
Insights from investors, biopharma leaders and digital health executives on how to navigate the digital health sector as it transforms every aspect of the pharmaceutical value chain.